Rick Doblin, the founder of MAPS (the Multidisciplinary Association for Psychedelic Studies) explains why MDMA, psilocybin, LSD, and related drugs are finally ready for prime time.
'Welcome to the psychedelic '20s!'
'Welcome to the psychedelic '20s!'
'Welcome to the psychedelic '20s!'
Rick Doblin, the founder of MAPS (the Multidisciplinary Association for Psychedelic Studies) explains why MDMA, psilocybin, LSD, and related drugs are finally ready for prime time.